Organization | University of Baghdad

University of Baghdad Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Baghdad Iraq (1957)

Organization Overview

First Clinical Trial

2014

NCT02935738

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Alhasan Mujtaba Abdul-Wahid | Al-Kindy College of Medicine | Al-Kindy college of Medicine, University of Baghdad | Al Kindy College of Medicine, University of Baghdad | Al-Rasheed University College | Baghdad college of dentistry, Department of orthodontics | Baghdad College of Medicine | Baghdad College of Medicine/ University of Baghdad | Baghdad Teaching Hospital | Baghdad university | Baghdad University- College of Dentistry | Baghdad University/College of Pharmacy/Department of Biochemistry | Baghdad University/College of Pharmacy/Department of Clinical Pharmacy | collage of dentistry- Baghdad university | College of Dentistry/ University of Baghdad | College of Medicine-University of Baghdad | Faiq Gorial | Global Stem Cell Center, Baghdad | Lewai Sharki Abdulaziz, MSc PhD | MOHAMED SAEED M. ALI | Najaf dental specialized center | Professor of Rheumatolgy,Baghdad University | Suzan Rattan | univeristy of baghdad | University of Baghdad | University of Baghdad- Alkindy collage of medicine | University of Baghdad - Al-Kindy College of Medicine | University of Baghdad / College of Dentistry | University of Baghdad/ College of Dentistry | University of Baghdad\ College of Dentistry | University of Baghdad, College of Medicine | Zainab J Abbas

Active Ingredients

Drugs in Phase 4 Trials (17)

bortezomib (velcade) (1 trial)

butamben (1 trial)

carbetocin (Pabal) (1 trial)

chlorhexidine (hibitane) (6 trials)

dexamethasone (1 trial)

epinephrine (levophed) (1 trial)

eugenol (1 trial)

fenofibrate (fenoglide) (1 trial)

gabapentin (neurontin) (1 trial)

lidocaine (xylocaine) (2 trials)

moxifloxacin (avelox) (1 trial)

niacin (1 trial)

oxytocin (syntocinon) (1 trial)

pregabalin (lyrica) (1 trial)

sodium bicarbonate (1 trial)

triamcinolone (kenalog) (1 trial)

Drugs in Phase 3 Trials (17)

acetaminophen (tylenol) (1 trial)

amoxicillin (1 trial)

calcium fluoride (1 trial)

diclofenac (voltaren) (1 trial)

escin (1 trial)

hyaluronic acid (1 trial)

hydrogen peroxide (1 trial)

hydroxyethylrutoside (1 trial)

levothyroxine (Synthroid) (1 trial)

melatonin (3 trials)

metronidazole (flagyl) (1 trial)

nitroglycerin (transderm-nitro) (2 trials)

omega-3 fatty acids (Omacor) (1 trial)

platelet rich fibrin (4 trials)

silver diammine fluoride (1 trial)

sodium fluoride (18F) (2 trials)

trypsin (1 trial)

Drugs in Phase 2 Trials (11)

aloe vera (1 trial)

cabergoline (dostinex) (1 trial)

colgate total (1 trial)

etanercept (enbrel) (1 trial)

lycopene (1 trial)

metformin (glucophage) (2 trials)

minocycline (minocin) (1 trial)

niclosamide (nicloside) (2 trials)

ozone (3 trials)

spironolactone (aldactone) (1 trial)

water (1 trial)

Drugs in Phase 1 Trials (10)

azithromycin (zithromax) (1 trial)

cinnamon (1 trial)

colchicine (colbenemid) (1 trial)

curcumin (2 trials)

dibotermin alpha (inductos) (1 trial)

diltiazem (cardizem) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

ivermectin (stromectol) (1 trial)

resveratrol (1 trial)

tribenoside (1 trial)

Drugs in Other Trials (9)

casein phosphopeptide amorphous calcium phosphate (1 trial)

lysergic acid diethylamide (1 trial)

midazolam (versed) (1 trial)

pelargonium (1 trial)

platelet-rich plasma (1 trial)

prednisone (meticorten) (1 trial)

pyridoxine (1 trial)

silver fluoride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acute Kidney Injury (Phase 2)

Adenomatous Polyps (Phase 1)

Alveolar Bone Loss (Phase 3)

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Chronic Disease (Phase 1)

Chronic Periodontitis (Phase 1)

Colonic Polyps (Phase 1)

Colorectal Neoplasms (Phase 1)

Dental Caries (Phase 3)

Dyslipidemias (Phase 4)

Emergencies (Phase 4)

Endophthalmitis (Phase 4)

Gingivitis (Phase 2)

Hemorrhage (Phase 4)

Multiple Myeloma (Phase 4)

Neoplasms, Plasma Cell (Phase 4)

Pelvic Pain (Phase 1)

Periodontal Pocket (Phase 2)

Periodontitis (Phase 1)

Postpartum Hemorrhage (Phase 4)

Prostatitis (Phase 1)

Somatoform Disorders (Phase 1)

Syndrome (Phase 1)

Wounds and Injuries (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 48
# of Trial APIs: 64